182 related articles for article (PubMed ID: 15342619)
1. Intramuscular haloperidol or lorazepam and QT intervals in schizophrenia.
Harvey AT; Flockhart D; Gorski JC; Greenblatt DJ; Burke M; Werder S; Preskorn SH
J Clin Pharmacol; 2004 Oct; 44(10):1173-84. PubMed ID: 15342619
[TBL] [Abstract][Full Text] [Related]
2. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.
Tisdale JE; Kovacs R; Mi D; McCabe GP; Cariera BL; Sharma N; Rosman H
Pharmacotherapy; 2007 Feb; 27(2):175-82. PubMed ID: 17253907
[TBL] [Abstract][Full Text] [Related]
4. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
[TBL] [Abstract][Full Text] [Related]
5. Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial.
Huang CL; Hwang TJ; Chen YH; Huang GH; Hsieh MH; Chen HH; Hwu HG
J Formos Med Assoc; 2015 May; 114(5):438-45. PubMed ID: 25791540
[TBL] [Abstract][Full Text] [Related]
6. QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study.
Zhang L; Chappell J; Gonzales CR; Small D; Knadler MP; Callaghan JT; Francis JL; Desaiah D; Leibowitz M; Ereshefsky L; Hoelscher D; Leese PT; Derby M
J Cardiovasc Pharmacol; 2007 Mar; 49(3):146-53. PubMed ID: 17414226
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
[TBL] [Abstract][Full Text] [Related]
8. Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
Berling I; Isbister GK
Ann Emerg Med; 2015 Aug; 66(2):154-64. PubMed ID: 25639523
[TBL] [Abstract][Full Text] [Related]
9. Effect of a single supratherapeutic dose of dolutegravir on cardiac repolarization.
Chen S; Min SS; Peppercorn A; Borland J; Lou Y; Song I; Fujiwara T; Piscitelli SC
Pharmacotherapy; 2012 Apr; 32(4):333-9. PubMed ID: 22422361
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers.
Wang Z; Grasela DM; Krishna G
Clin Ther; 2007 Jun; 29(6):1098-106. PubMed ID: 17692724
[TBL] [Abstract][Full Text] [Related]
11. QT analysis: a complex answer to a 'simple' problem.
Li L; Desai M; Desta Z; Flockhart D
Stat Med; 2004 Sep; 23(17):2625-43. PubMed ID: 15316947
[TBL] [Abstract][Full Text] [Related]
12. Variability of heart rate correction methods for the QT interval.
Desai M; Li L; Desta Z; Malik M; Flockhart D
Br J Clin Pharmacol; 2003 Jun; 55(6):511-7. PubMed ID: 12814443
[TBL] [Abstract][Full Text] [Related]
13. Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior.
Salzman C; Solomon D; Miyawaki E; Glassman R; Rood L; Flowers E; Thayer S
J Clin Psychiatry; 1991 Apr; 52(4):177-80. PubMed ID: 1673123
[TBL] [Abstract][Full Text] [Related]
14. Magnitude of error introduced by application of heart rate correction formulas to the canine QT interval.
King A; Bailie M; Olivier NB
Ann Noninvasive Electrocardiol; 2006 Oct; 11(4):289-98. PubMed ID: 17040276
[TBL] [Abstract][Full Text] [Related]
15. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
16. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
Weiden PJ; Cutler AJ; Polymeropoulos MH; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908
[TBL] [Abstract][Full Text] [Related]
17. Autonomic tone attenuates drug-induced QT prolongation.
Smith AH; Norris KJ; Roden DM; Kannankeril PJ
J Cardiovasc Electrophysiol; 2007 Sep; 18(9):960-4. PubMed ID: 17666066
[TBL] [Abstract][Full Text] [Related]
18. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
19. Effects on prolongation of Bazett's corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis.
Chung AK; Chua SE
J Psychopharmacol; 2011 May; 25(5):646-66. PubMed ID: 20826552
[TBL] [Abstract][Full Text] [Related]
20. Modulation of ventricular repolarization in patients with transient left ventricular apical ballooning: a case control study.
Bonnemeier H; Ortak J; Bode F; Kurowski V; Reppel M; Weitz G; Barantke M; Schunkert H; Wiegand UK
J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1340-7. PubMed ID: 17096660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
